Horizon Kinetics - PROGENICS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Horizon Kinetics ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2018$282,000
-33.0%
67,2000.0%0.01%
-10.0%
Q3 2018$421,000
-22.0%
67,2000.0%0.01%
-28.6%
Q2 2018$540,000
+7.8%
67,2000.0%0.01%
-6.7%
Q1 2018$501,000
+25.2%
67,2000.0%0.02%
+25.0%
Q4 2017$400,000
-19.2%
67,2000.0%0.01%
-20.0%
Q3 2017$495,000
+8.6%
67,200
-0.1%
0.02%0.0%
Q2 2017$456,000
-28.2%
67,2600.0%0.02%
-25.0%
Q1 2017$635,000
+9.3%
67,260
+0.1%
0.02%
+5.3%
Q4 2016$581,000
+36.7%
67,2000.0%0.02%
+58.3%
Q3 2016$425,000
+49.6%
67,2000.0%0.01%
+71.4%
Q2 2016$284,000
-3.1%
67,2000.0%0.01%0.0%
Q1 2016$293,000
-28.9%
67,2000.0%0.01%
-22.2%
Q4 2015$412,000
+7.3%
67,2000.0%0.01%
+28.6%
Q3 2015$384,000
-23.4%
67,2000.0%0.01%0.0%
Q2 2015$501,000
+24.6%
67,2000.0%0.01%
+16.7%
Q1 2015$402,000
-20.9%
67,2000.0%0.01%
-14.3%
Q4 2014$508,000
+45.6%
67,2000.0%0.01%
+75.0%
Q3 2014$349,000
+20.3%
67,2000.0%0.00%0.0%
Q2 2014$290,000
+5.5%
67,2000.0%0.00%
+33.3%
Q1 2014$275,000
-23.2%
67,2000.0%0.00%
-40.0%
Q4 2013$358,000
+6.2%
67,2000.0%0.01%0.0%
Q3 2013$337,000
+12.3%
67,2000.0%0.01%
+25.0%
Q2 2013$300,00067,2000.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 6,158,000$38,611,0002.32%
ARDSLEY ADVISORY PARTNERS LP 2,045,000$12,822,0001.73%
RA Capital Management 3,030,303$19,000,0001.02%
Phocas Financial Corp. 1,736,386$10,887,0000.95%
ARDSLEY ADVISORY PARTNERS LP 500,000$3,135,0000.42%
RICE HALL JAMES & ASSOCIATES, LLC 1,345,260$8,435,0000.30%
BKS ADVISORS, LLC 115,115$721,0000.26%
PINNACLE ASSOCIATES LTD 1,530,657$9,597,0000.20%
CARILLON TOWER ADVISERS, INC. 3,948,024$24,745,0000.18%
EAGLE ASSET MANAGEMENT INC 4,444,673$27,868,0000.14%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders